Journey Clinical raises $ 3 million to enable psychotherapists to prescribe psychedelics - TechCrunch
Summary
The latest is New York-based Journey Clinical, which raised a $ 3 million funding round led by San Francisco-based venture capital firm Fifty Years. Jonathan Sabbagh, co-founder and CEO, was previously diagnosed with PTSD, but after learning about psychedelics, he returned to school to study clinical psychology and co-founded Journey. “ Speaking to TechCrunch, he added, “When we asked what was the main bottleneck for therapists to offer KAP to their patients, the # 1 answer was access to a prescribing physician. Our alpha testing group confirmed that ensuring access to a trained medical team and creating a robust care management system would address a critical bottleneck in the widespread adoption of KAP. Ela Madej, Founding Partner of Fifty Years, said: “I dream of a world where those of us affected by trauma, anxiety or depression do not have to fall into learned helplessness.